School of Mathematics, Statistics, and Computer Science, College of Science, University of Tehran, Tehran, Iran.
Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Mol Med. 2019 Aug 1;25(1):36. doi: 10.1186/s10020-019-0106-1.
Acute lymphoblastic leukemia (ALL) is the most common type of cancer diagnosed in children and Glucocorticoids (GCs) form an essential component of the standard chemotherapy in most treatment regimens. The category of infant ALL patients carrying a translocation involving the mixed lineage leukemia (MLL) gene (gene KMT2A) is characterized by resistance to GCs and poor clinical outcome. Although some studies examined GC-resistance in infant ALL patients, the understanding of this phenomenon remains limited and impede the efforts to improve prognosis.
This study integrates differential co-expression (DC) and protein-protein interaction (PPI) networks to find active protein modules associated with GC-resistance in MLL-rearranged infant ALL patients. A network was constructed by linking differentially co-expressed gene pairs between GC-resistance and GC-sensitive samples and later integrated with PPI networks by keeping the links that are also present in the PPI network. The resulting network was decomposed into two sub-networks, specific to each phenotype. Finally, both sub-networks were clustered into modules using weighted gene co-expression network analysis (WGCNA) and further analyzed with functional enrichment analysis.
Through the integration of DC analysis and PPI network, four protein modules were found active under the GC-resistance phenotype but not under the GC-sensitive. Functional enrichment analysis revealed that these modules are related to proteasome, electron transport chain, tRNA-aminoacyl biosynthesis, and peroxisome signaling pathways. These findings are in accordance with previous findings related to GC-resistance in other hematological malignancies such as pediatric ALL.
Differential co-expression analysis is a promising approach to incorporate the dynamic context of gene expression profiles into the well-documented protein interaction networks. The approach allows the detection of relevant protein modules that are highly enriched with DC gene pairs. Functional enrichment analysis of detected protein modules generates new biological hypotheses and may help in explaining the GC-resistance in MLL-rearranged infant ALL patients.
急性淋巴细胞白血病(ALL)是儿童中最常见的癌症类型,糖皮质激素(GCs)是大多数治疗方案中标准化疗的重要组成部分。携带混合谱系白血病(MLL)基因(基因 KMT2A)易位的婴儿 ALL 患者类别对 GCs 具有耐药性,临床预后不良。尽管一些研究检查了婴儿 ALL 患者的 GC 耐药性,但对这种现象的理解仍然有限,这阻碍了改善预后的努力。
本研究通过差异共表达(DC)和蛋白质 - 蛋白质相互作用(PPI)网络的整合,找到与 MLL 重排婴儿 ALL 患者 GC 耐药相关的活跃蛋白模块。通过将 GC 耐药和 GC 敏感样本之间差异共表达基因对之间的连接构建网络,然后通过保留也存在于 PPI 网络中的连接将其与 PPI 网络集成。所得网络被分解为两个子网络,分别针对每个表型。最后,使用加权基因共表达网络分析(WGCNA)将两个子网络聚类为模块,并进一步进行功能富集分析。
通过 DC 分析和 PPI 网络的整合,发现了在 GC 耐药表型下活跃但在 GC 敏感表型下不活跃的四个蛋白质模块。功能富集分析表明,这些模块与蛋白酶体、电子传递链、tRNA-氨酰基生物合成和过氧化物酶体信号通路有关。这些发现与先前在其他血液恶性肿瘤(如儿科 ALL)中与 GC 耐药相关的发现一致。
差异共表达分析是一种很有前途的方法,可以将基因表达谱的动态背景纳入经过充分记录的蛋白质相互作用网络中。该方法允许检测到与差异共表达基因对高度富集的相关蛋白质模块。检测到的蛋白质模块的功能富集分析产生了新的生物学假设,并可能有助于解释 MLL 重排婴儿 ALL 患者的 GC 耐药性。